A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

Part of paid clinical trials in Houston, Texas.

Sponsor
The University of Texas Health Science Center, Houston
Study ID
NCT05735314
Status
Recruiting
Apply to this trial

Conditions

  • Anemia
  • Decreased Glomerular Filtration Rate

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Enhanced diagnostic team implementing three evidence-based interventions — OTHER
    we designed an enhanced team process entailing: 1) using automated abnormal test result detection and tracking; 2) expanding the primary care team to include CPs to guide the evaluation of anemia to identify underlying causes; and 3) using NNs to engage patients in the healthcare team and diagnostic process and increase patient activation.
  • Usual care — OTHER
    Usual care involves primary care physicians ordering additional tests and referrals to evaluate patients with new anemia and decreased glomerular filtration rate (GFR) .

Study Details

The purpose of this study is to measure the evidence-based intervention's (EBIs) impact on patient safety and efficiency, to assess the EBIs implementation by measuring acceptability, appropriateness, cost, fidelity, penetration, and sustainability and to identify the facilitators and barriers that influence the degree of implementation of these EBIs.

Key Dates

Start date
Jan 8, 2024
Status verified
Dec 2025
Primary completion
Jul 16, 2026
Completion
Jul 16, 2026

Study Design

Enrollment
450 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Experimental: Step 1 (3 clinics) - 24 months of intervention
  • Experimental: Experimental: Step 2 (3 clinics) - 1 month of control followed by 18 months of intervention
  • Experimental: Experimental: Step 3 (3 clinics) - 2 months control followed by 12 months of intervention
  • Experimental: Experimental: Step 4 (4 clinics) - 2 months control followed by 12 months of intervention

Primary Outcome Measure

Percentage of subjects who have correct diagnosis of cause of low hemoglobin [ Time Frame: within 6 months from baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Texas Health Science Center at HoustonHoustonTexas77030
Eric Thomas, MD, MPH
[email protected]
713-500-7958
Eric Thomas
[email protected]
713-500-7958

Find similar trials in Houston, TX

By research site
The University of Texas Health Science Center at Houston· Houston, TX

Related Studies